You think Bristol Myers buying RayzeBio for USD$4.1 billion (AUD$6.16B) make TLX look cheap at market cap of AUD$6.3B (including the 17m shares for Nasdaq). Comparing the pipeline of drugs between the 2 companies are miles ahead. RayzeBio seems to only have 4 pipelines based on (https://rayzebio.com/pipeline/pipeline-overview/). You would think TLX is worth at least double what it is now.
You think Bristol Myers buying RayzeBio for USD$4.1 billion...
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.63 |
Change
0.500(2.61%) |
Mkt cap ! $6.568B | |||
| Open | High | Low | Value | Volume |
| $19.20 | $19.66 | $19.15 | $19.89M | 1.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 774 | $19.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.65 | 8138 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |